US FDA Gives Its Two-Cents On Nickel-Titanium Alloys
Executive Summary
Nitinol, a nickel-titanium alloy ubiquitous in medical devices, is getting more scrutiny from US FDA in a recently released draft guidance. As safety concerns have arisen in the past few years over biocompatibility of certain materials in implanted products, the agency is asking device makers to provide additional information on nitinol in their device submissions.
You may also be interested in...
FDA Will Hold Advisory Panel Meeting In Fall On Metal Implant Reactivity
US FDA Commissioner Scott Gottlieb and device center director Jeffrey Shuren reminded the public on March 15 that materials in devices – including metals in orthopedic products and defibrillators – can cause reactions in some patients. They said the agency needs to do "more work” on patient responses to metal implants and other biomaterials, and announced an FDA advisory panel meeting this fall on reactions to metals.
Corrosion Testing For Nickel Stents Front And Center In FDA Final Update
The agency says it has taken into account feedback from industry during a 2013 workshop on the risks of nickel stents, and has reduced its requirements for standard corrosion testing while also outlining steps on when to adopt different corrosion testing methods.
Massive Family Dollar Rat Infestation Leads To Multi-State Recall
The US FDA found more than 2,000 rats at an Arkansas Family Dollar distribution center, leadingto a six-state recall for products including feminine hygiene products, contact lens cleaners and face masks.